MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide and has a poor prognosis. Current treatments for advanced NSCLC included traditional chemotherapy, radiotherapy, targeted therapy, and immunotherapy. The efficacy of targeted therapy relies on oncogene addictio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hongge, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104217/
https://www.ncbi.nlm.nih.gov/pubmed/32273721
http://dx.doi.org/10.2147/OTT.S231257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104217/
https://www.ncbi.nlm.nih.gov/pubmed/32273721
http://dx.doi.org/10.2147/OTT.S231257

Ejemplares similares